BioXcel Therapeutics (BTAI) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-8.09
-5.46
-2.84
-0.21

Details

Expected EPS
-2.72
Actual EPS
-1.5
Surprise EPS
1.22
Surprise Percent
+44.85%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -1.5 per share for Q2 2025.

0 Comments

Share your thoughts